|
Volumn 465, Issue 1-2, 2014, Pages 175-186
|
A novel nano-carrier transdermal gel against inflammation
|
Author keywords
Drug delivery; Nano carrier; Nano transfersomes; Stability; Toxicity; Transdermal gel
|
Indexed keywords
DICLOFENAC DIETHYLAMINE;
NANOCARRIER;
ACRYLIC ACID DERIVATIVE;
ANTIINFLAMMATORY AGENT;
CARBOMER;
CARRAGEENAN;
CURCUMIN;
DICLOFENAC;
DRUG CARRIER;
DRUG COMBINATION;
GEL;
NANOPARTICLE;
ABSORPTION;
ADULT;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
BIOLOGICAL ACTIVITY;
BLOOD SAMPLING;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG HALF LIFE;
DRUG SAFETY;
ERYTHEMA;
GEL;
IN VIVO STUDY;
INFLAMMATION;
LIQUID CHROMATOGRAPHY;
MAXIMUM PLASMA CONCENTRATION;
MEAN RESIDENCE TIME;
NANOENCAPSULATION;
NONHUMAN;
PH;
PLASMA CONCENTRATION-TIME CURVE;
PRIORITY JOURNAL;
RAT;
SKIN EDEMA;
SKIN IRRITATION;
TANDEM MASS SPECTROMETRY;
TIME TO MAXIMUM PLASMA CONCENTRATION;
TRANSDERMAL DRUG ADMINISTRATION;
ANIMAL;
BIOAVAILABILITY;
BLOOD;
CHEMICALLY INDUCED;
CHEMISTRY;
DISEASE MODEL;
DRUG ADMINISTRATION;
DRUG COMBINATION;
DRUG EFFECTS;
DRUG STABILITY;
INTRADERMAL DRUG ADMINISTRATION;
MALE;
MEDICINAL CHEMISTRY;
NANOTECHNOLOGY;
PATHOLOGY;
PHARMACEUTICS;
PROCEDURES;
SKIN;
TOXICITY;
TOXICITY TESTING;
WISTAR RAT;
DRUG ABSORPTION;
DRUG RELEASE;
ELIMINATION RATE CONSTANT;
HISTOCOMPATIBILITY;
NANOCARRIER TRANSDERMAL GEL;
PAW EDEMA;
PHARMACODYNAMICS;
TRANSDERMAL DRUG DELIVERY SYSTEM;
ACRYLATES;
ADMINISTRATION, CUTANEOUS;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
BIOLOGICAL AVAILABILITY;
CARRAGEENAN;
CHEMISTRY, PHARMACEUTICAL;
CHROMATOGRAPHY, LIQUID;
CURCUMIN;
DICLOFENAC;
DISEASE MODELS, ANIMAL;
DRUG ADMINISTRATION SCHEDULE;
DRUG CARRIERS;
DRUG COMBINATIONS;
DRUG STABILITY;
GELS;
INFLAMMATION;
MALE;
NANOPARTICLES;
NANOTECHNOLOGY;
RATS, WISTAR;
SKIN;
SKIN IRRITANCY TESTS;
TANDEM MASS SPECTROMETRY;
TECHNOLOGY, PHARMACEUTICAL;
|
EID: 84898597514
PISSN: 03785173
EISSN: 18733476
Source Type: Journal
DOI: 10.1016/j.ijpharm.2014.02.023 Document Type: Article |
Times cited : (39)
|
References (18)
|